Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis66

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis27

Views

Views
December 20253
January 20261
February 20263
March 20266
April 20260
May 20264
June 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Netherlands8
South Africa2
Argentina2
Australia1
Ecuador1
Finland1
Kenya1
 

Top cities views

Views
Groningen8
Boca Toma1
Grand Bourg1
Helsinki1
Huntsville1
Klerksdorp1
Nairobi1
Quito1
Santa Clara1
Surprise1